Vaginal microbicides.
The focus of this review will be to highlight articles from 2000 and up to August 2001 that demonstrate the challenges in the evaluation of candidate microbicides, and the ways in which investigators have approached these challenges.
McCormack
Sheena
S
MRC Clinical Trials Unit, 222 Euston Road, London NW1 2DA, UK. s.mccormack@ctu.mrc.ac.uk
D000282:Administration, Intravaginal; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D010349:Patient Compliance; D012749:Sexually Transmitted Diseases / Q000188:drug therapy*
D019380:Anti-HIV Agents; D000890:Anti-Infective Agents